Strides Pharma Science Limited is a global pharmaceutical company engaged in the development, manufacturing, and commercialization of generic medicines, specialty pharmaceuticals, and over-the-counter healthcare products. Established in 1990, the company has built a diversified business with a strong presence across regulated and emerging markets, including the United States, Europe, Australia, and Africa. Strides specializes in complex oral solid dosages, soft gel capsules, sterile products, and niche therapeutic formulations. The company operates internationally accredited manufacturing facilities that comply with major global regulatory standards, supporting partnerships with healthcare organizations and pharmaceutical companies worldwide. Through continuous investment in research, product development, and manufacturing technologies, Strides focuses on expanding its portfolio of differentiated and value-added medicines. Its commitment to quality, affordability, and operational efficiency has enabled the company to strengthen its competitive position in the global generic pharmaceutical industry while serving millions of patients across international markets.
NSE: STAR | BSE: 532531
Bengaluru, Karnataka, India
~5,500 employees
